Surgery, squash and anaesthesia
Hannah (18) wants to become a doctor. After two days job shadowing doctors and nurses at the Norwegian Radium Hospital, she is even more certain that this is what she wants to do.
Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
We are happy to be able to announce that ReproUnion has been granted funding for the continuance of the ReproUnion project, which will help establish and further develop the Medicon Valley region as a world-class life science cluster within infertility treatment.
Roche is looking for new partners in the innovative Norwegian life science scene.
UNOPS, the UN Office for Project Services have decided to open a global innovation centre in Sweden and Lund in collaboration with Ideon Science Park. The venture is funded by Vinnova. The new centre is the second science and innovation centre launched by UNOPS this year, following the launch of a similar initiative in Antigua and Barbuda. This is a part of their strategy to reach the global development goals within Agenda 2030.
Export-driven growth in life science will to an increasing extent depend on the demands of the growing Chinese markets, but how do we keep the engine running?
SmiLe company Saga Diagnostics has been chosen following tough competition to be awarded a grant through Swelife’s “Project for better health, step 2” and will receive SEK 4.7 million. In addition to being a member of SmiLe Incubator, Saga is included in LU Holding’s portfolio of companies. Of the 22 projects that were evaluated, only eight receive funding and half of them come from Lund.
Sinntaxis in Lund has been awarded SEK 500,000 under the SME instrument phase 1 program within the EU Horizon 2020 framework. The grant money will be used to advance the business plan and the regulatory work to initiate a phase II clinical trial in stroke recovery.
Donations include $30 million to Communities In Schools, $10 million to City Year and $15 million to University of Chicago Education Lab. The contributions will significantly expand and strengthen programs to provide vulnerable children across the country with academic, social and emotional support to help them achieve their full potential.
Starting next year, Oslo Cancer Cluster will co-power the conference E-health in Norway (EHiN)
Elagolix, in combination with add-back therapy, achieved statistically significant reduction in heavy menstrual bleeding associated with uterine fibroids compared to placebo
The High Level Forum (HLF) is an international Forum devoted to “Leading Innovation Ecosystems” and managed by the Grenoble Innovation Campus GIANT. This annual event is attended by an international community of High Level Executives – Decision and Policy makers, all deeply engaged in the management or promotion of Innovation, from the worlds of education, research, industry, business and public authorities.
EXPEDITION-8 is the first Phase 3b study evaluating 8 weeks of MAVYRET™ in treatment-naïve chronic hepatitis C virus (HCV)-infected patients with compensated cirrhosis across all major genotypes (GT1-6)
During Bio Europe, we had the opportunity to talk with reporter, Flora Southey, from British BioPharma Reporter, who was curious about the Medicon Valley idea, the current challenges and how we at Medicon Valley Alliance try to make it work on a daily basis.